ALNY

NASDAQ

Alnylam Pharmaceuticals Inc — Quarterly Earnings

Beat estimates 54% of the time in last 87 quarters

EPS History — Last 8 Quarters

Green = beat estimate · Red = missed · Gray = estimate

Quarterly Results87 quarters
PeriodReport DateEst. EPSActual EPSSurpriseSurprise %
2025-12Feb 12, 2026$1.24$1.25+$0.01 +0.81%
2025-09Oct 30, 2025$1.44$2.90+$1.46 +101.39%
2025-06Jul 31, 2025-$0.70-$0.51+$0.19 +27.14%
2025-03May 1, 2025-$0.37-$0.01+$0.36 +97.30%
2024-12Feb 13, 2025-$0.14$0.06+$0.20 +142.86%
2024-09Oct 31, 2024-$0.39-$0.50$0.11 -28.21%
2024-06Aug 1, 2024-$1.08-$0.13+$0.95 +87.96%
2024-03May 2, 2024-$1.18-$0.52+$0.66 +55.93%

Data sourced from Alpha Vantage. EPS values are diluted EPS (GAAP).